. 2019 Dec 9;19(2):1024–1032. doi: 10.3892/etm.2019.8305

Table VII.

Important clinical events of patients with ATIII.

Days	ATIII ≥55.7% n=47	ATIII <55.7% n=22	P-value	χ²-value
HLOS	15.33±10.12	18.18±17.85	0.623	−0.505
ICU hospital stay	10.44±6.08	22.73±18.00	0.049^a	−2.225
Duration of no vasoactive drug use	26.50±4.30	15.28±13.52	0.072	2.134
No mechanical ventilation time	25.17±4.41	11.28±14.17	0.041^a	2.521
No CRRT time	26.58±4.91	13.71±12.66	0.036^a	2.579
Survival time	24.36±6.97	17.95±11.32	0.021^a	2.446

ICULOS, Intensive care unit length of stay; HLOS, Hospital length of stay; CRRT, Continuous renal replacement therapy; ATIII, antithrombin.

P<0.05.